Lixte Biotechnology Holdings, Inc.
At Close: 4:00 PM
LIXT Stock Price Graph
LIXT Stock Price Today
Lixte Biotechnology Holdings, Inc. (LIXT) stock rallied over 4.03% intraday to trade at $3.1 a share on NASDAQ. The stock opened with a loss of -17.57% at $2.44 and touched an intraday high of $2.51, rising 4.73% against the last close of $2.96. The Lixte Biotechnology Holdings, Inc. in stock market went to a low of $2.34 during the session.
LIXT Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
LIXT Stock Price History Chart
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. The company was founded in 2005 and is based in Pasadena, California.
Frequently Asked Questions
What is the current Lixte Biotechnology Holdings, Inc. (LIXT) stock price?
Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) stock price is $3.10 in the last trading session. During the trading session, LIXT stock reached the peak price of $2.51 while $2.34 was the lowest point it dropped to. The percentage change in LIXT stock occurred in the recent session was 4.03% while the dollar amount for the price change in LIXT stock was $0.12.
LIXT's industry and sector of operation?
The NASDAQ listed LIXT is part of Biotechnology industry that operates in the broader Healthcare sector. Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets.
Who are the executives of LIXT?
Mr. Robert Neal Weingarten
Vice President & Chief Financial Officer
Mr. Eric J. Forman J.D.
Vice President & Chief Operating Officer
Dr. John S. Kovach M.D.
Founder, Pres, Chief Executive Officer, Chief Scientific Officer & Chairman
Dr. John S. Kovach M.D.
Founder, Pres, CEO, Chief Scientific Officer & Chairman
How LIXT did perform over past 52-week?
LIXT's closing price is 0.24% higher than its 52-week low of $1.58 where as its distance from 52-week high of $27 is -0.80%.
How many employees does LIXT have?
Number of LIXT employees currently stands at 4.00. LIXT operates from 680 East Colorado Boulevard, Pasadena, CA 91101, US.
Link for LIXT official website?
Official Website of LIXT is: https://lixte.com
How do I contact LIXT?
How many shares of LIXT are traded daily?
LIXT stock volume for the day was 791019.00 shares. The average number of LIXT shares traded daily for last 3 months was 42.49 Thousands.
What is the market cap of LIXT currently?
The market value of LIXT currently stands at $6.97 Million with its latest stock price at $3.10 and 2.25 Million of its shares outstanding.